Immunome is a biopharmaceutical company focused on developing antibody therapeutics for cancer and infectious diseases. Their lead program targets a tumor-derived immune checkpoint that helps cancer cells evade the immune system. They are also developing an antibody cocktail for the treatment of SARS-CoV-2 infections and COVID-19. Founded in 2006, Immunome is based in Exton, Pennsylvania.